Last reviewed · How we verify

NCT07364695

Early Postoperative Function After Open Versus Ultrasound-Guided Trigger Finger Release

Completed Last updated 25 March 2026
What this trial tests

trial testing UltraGuideTFR (Sonex Health, MN, USA) in Trigger Finger in 60 participants. Completed in 31 December 2024.

Timeline
20 June 2023
Primary endpoint
26 June 2024
31 December 2024

Quick facts

Lead sponsorMassachusetts General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date20 June 2023
Primary completion26 June 2024
Estimated completion31 December 2024
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts General Hospital

Who can join

18 and older, any sex, with Trigger Finger. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical outcomes after open trigger finger release are excellent. Minimally invasive techiques with ultrasound guidance theoretically offer advantages for faster recovery but this technique has not been compared prospectively with the standard of care (open trigger release). This study aims to prospectively analyze patient-reported outcomes in patients undergoing open vs. ultrasound-guided trigger finger release.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Trigger Finger

Currently open trials in the same condition.

Other Massachusetts General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07364695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing